These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35504189)

  • 1. Lipocalin-2 does not influence EAE clinical score but it increases inflammation in central nervous system.
    das Neves SP; Serre-Miranda C; Sousa JC; Costa PS; Sousa N; Cerqueira JJ; Marques F
    J Neuroimmunol; 2022 Jul; 368():577872. PubMed ID: 35504189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
    Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
    J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin 2 attenuates oligodendrocyte loss and immune cell infiltration in mouse models for multiple sclerosis.
    Gasterich N; Bohn A; Sesterhenn A; Nebelo F; Fein L; Kaddatz H; Nyamoya S; Kant S; Kipp M; Weiskirchen R; Zendedel A; Beyer C; Clarner T
    Glia; 2022 Nov; 70(11):2188-2206. PubMed ID: 35856297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expression.
    Kalinin S; Feinstein DL
    Neurosci Lett; 2023 Oct; 815():137497. PubMed ID: 37748675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipocalin-2 promotes adipose-macrophage interactions to shape peripheral and central inflammatory responses in experimental autoimmune encephalomyelitis.
    Sciarretta F; Ceci V; Tiberi M; Zaccaria F; Li H; Zhou ZY; Sun Q; Konja D; Matteocci A; Bhusal A; Verri M; Fresegna D; Balletta S; Ninni A; Di Biagio C; Rosina M; Suk K; Centonze D; Wang Y; Chiurchiù V; Aquilano K; Lettieri-Barbato D
    Mol Metab; 2023 Oct; 76():101783. PubMed ID: 37517520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
    Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
    Front Immunol; 2019; 10():2437. PubMed ID: 31681317
    [No Abstract]   [Full Text] [Related]  

  • 9. The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.
    Gur-Wahnon D; Mizrachi T; Maaravi-Pinto FY; Lourbopoulos A; Grigoriadis N; Higazi AA; Brenner T
    J Neuroinflammation; 2013 Oct; 10():124. PubMed ID: 24120085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis.
    Rodrigues DH; Lacerda-Queiroz N; de Miranda AS; Fagundes CT; Campos RD; Arantes RE; Vilela Mde C; Rachid MA; Teixeira MM; Teixeira AL
    Brain Res; 2011 Apr; 1385():298-306. PubMed ID: 21338585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
    Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
    J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SOCS2 in the Regulation of Immune Response and Development of the Experimental Autoimmune Encephalomyelitis.
    Cramer A; de Lima Oliveira BC; Leite PG; Rodrigues DH; Brant F; Esper L; Pimentel PMO; Rezende RM; Rachid MA; Teixeira AL; Faria AMC; Teixeira MM; Machado FS
    Mediators Inflamm; 2019; 2019():1872593. PubMed ID: 31949423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
    Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production.
    Zorzella-Pezavento SF; Chiuso-Minicucci F; França TG; Ishikawa LL; da Rosa LC; Marques C; Ikoma MR; Sartori A
    Mediators Inflamm; 2013; 2013():519627. PubMed ID: 23970813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.
    Hu X; Wetsel RA; Ramos TN; Mueller-Ortiz SL; Schoeb TR; Barnum SR
    Immunobiology; 2014 Feb; 219(2):104-8. PubMed ID: 24028840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.